Commercial Physical & Biological Research (Services) Companies
FilingsAtlas covers 12 publicly traded US companies in the Commercial Physical & Biological Research (Services) industry (SEC SIC code 8731). Together they are worth about $100.66B in market value; the largest are Iqvia (IQV), Incyte (INCY), Medpace (MEDP). By revenue, the biggest is Iqvia with $16.31B in fiscal 2025. 5 of the 12 companies with a reported fiscal year were profitable.
| # | Company | Ticker | Market Cap | Revenue (latest FY) | Net Income | Revenue YoY | P/E |
|---|---|---|---|---|---|---|---|
| 1 | Iqvia Holdings Inc. | IQV | $43.61B | $16.31B FY2025 | $1.36B | +5.9% | 33.2 |
| 2 | Incyte Corp | INCY | $22.62B | $5.14B FY2025 | $1.29B | +21.2% | 16.9 |
| 3 | Medpace Holdings, Inc. | MEDP | $17.41B | $2.53B FY2025 | $451.1M | +20.0% | 39.9 |
| 4 | Charles River Laboratories International, Inc. | CRL | $14.36B | $4.02B FY2025 | -$144.3M | -0.9% | — |
| 5 | Absci Corp | ABSI | $1.43B | $2.8M FY2025 | -$115.2M | -38.2% | — |
| 6 | OmniAb, Inc. | OABIW | $605.3M | $18.7M FY2025 | -$64.8M | -29.3% | — |
| 7 | National Research Corp | NRC | $443.9M | $137.4M FY2025 | $11.6M | -4.0% | 40.3 |
| 8 | Maxcyte, Inc. | MXCT | $103.0M | $33.0M FY2025 | -$44.6M | -14.5% | — |
| 9 | IB Acquisition Corp. | IBAC | $46.1M | $0 FY2025 | $3.4M | — | 49.4 |
| 10 | OneMedNet Corp | ONMD | $23.3M | $1.4M FY2025 | -$2.8M | +111.3% | — |
| 11 | iSpecimen Inc. | ISPC | $1.5M | $1.9M FY2025 | -$10.5M | -79.2% | — |
| 12 | bioAffinity Technologies, Inc. | BIAF | $1.3M | $6.2M FY2025 | -$14.9M | -34.2% | — |
Market cap and P/E use the latest closing price; revenue and net income are from each company's most recent annual report (10-K) filed with the SEC. Click a company for its full financial statements.